-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the official website of NMPA showed that the application for the listing of the 4 generic generic drug "ivabradine hydrochloride tablets" by Beijing Biopharmaceuticals has entered the approval status (registration number: CYHS1900783), and it is expected to be approved soon and become the first imitation in China.
Ivabradine is a purely heart rate-lowering drug that reduces heart rate by selectively and specifically inhibiting the If current of cardiac pacing.
At present, only the original research product ivabradine hydrochloride tablets is on the market in China.
Source: Insight database (http://db.
Beijing Baiao Pharmaceutical was founded by the Chinese Academy of Sciences on January 19, 1995 with a registered capital of 55 million yuan.